148 related articles for article (PubMed ID: 16394354)
1. Comparison of two systems of classification of leprosy based on number of skin lesions and number of body areas involved--a clinicopathological concordance study.
Rao PN; Sujai S; Srinivas D; Lakshmi TS
Indian J Dermatol Venereol Leprol; 2005; 71(1):14-9. PubMed ID: 16394354
[TBL] [Abstract][Full Text] [Related]
2. Does nerve examination improve diagnostic efficacy of the WHO classification of leprosy?
Mehndiratta RC; Patnaik A; John O; Rao PS
Indian J Dermatol Venereol Leprol; 2008; 74(4):327-30. PubMed ID: 18797051
[TBL] [Abstract][Full Text] [Related]
3. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
[TBL] [Abstract][Full Text] [Related]
4. Revalidation of various clinical criteria for the classification of leprosy--a clinic-pathological study.
Gupta R; Kar HK; Bharadwaj M
Lepr Rev; 2012 Dec; 83(4):354-62. PubMed ID: 23614253
[TBL] [Abstract][Full Text] [Related]
5. The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions.
Van Brakel WH; de Soldenhoff R; McDougall AC
Lepr Rev; 1992 Sep; 63(3):231-46. PubMed ID: 1343818
[TBL] [Abstract][Full Text] [Related]
6. Use of ML dipstick as a tool to classify leprosy patients.
Buhrer-Sekula S; Sarno EN; Oskam L; Koop S; Wichers I; Nery JA; Vieira LM; de Matos HJ; Faber WR; Klatser PR
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):456-63. PubMed ID: 11332289
[TBL] [Abstract][Full Text] [Related]
7. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of leprosy patients with 1 to 5 skin lesions with relevance to their grouping into paucibacillary or multibacillary disease.
Rao PN; Pratap D; Ramana Reddy AV; Sujai S
Indian J Dermatol Venereol Leprol; 2006; 72(3):207-10. PubMed ID: 16766835
[TBL] [Abstract][Full Text] [Related]
9. MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment.
Prasad PV; Babu A; Kaviarasan PK; Viswanathan P; Tippoo R
Indian J Dermatol Venereol Leprol; 2005; 71(4):242-5. PubMed ID: 16394431
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing multibacillary leprosy: a comparative evaluation of diagnostic accuracy of slit-skin smear, bacterial index of granuloma and WHO operational classification.
Bhushan P; Sardana K; Koranne RV; Choudhary M; Manjul P
Indian J Dermatol Venereol Leprol; 2008; 74(4):322-6. PubMed ID: 18797050
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations, diagnosis and classification of leprosy.
Murthy PK
J Indian Med Assoc; 2004 Dec; 102(12):678-9. PubMed ID: 15871350
[TBL] [Abstract][Full Text] [Related]
12. The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients.
Bührer-Sékula S; Visschedijk J; Grossi MA; Dhakal KP; Namadi AU; Klatser PR; Oskam L
Lepr Rev; 2007 Mar; 78(1):70-9. PubMed ID: 17518099
[TBL] [Abstract][Full Text] [Related]
13. Description of leprosy classification at baseline among patients enrolled at the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
Moura RS; Penna GO; Cardoso LP; de Andrade Pontes MA; Cruz R; de Sá Gonçalves H; Fernandes Penna ML; de Araújo Stefani MM; Bührer-Sékula S
Am J Trop Med Hyg; 2015 Jun; 92(6):1280-4. PubMed ID: 25940192
[TBL] [Abstract][Full Text] [Related]
14. Clinicohistopathological correlation in leprosy.
Mathur MC; Ghimire RB; Shrestha P; Kedia SK
Kathmandu Univ Med J (KUMJ); 2011; 9(36):248-51. PubMed ID: 22710532
[TBL] [Abstract][Full Text] [Related]
15. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era.
Singal A; Sonthalia S; Pandhi D
Lepr Rev; 2011 Sep; 82(3):259-69. PubMed ID: 22125934
[TBL] [Abstract][Full Text] [Related]
16. In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection.
Negesse Y; Beimnet K; Miko T; Wondimus A; Berhan TY
Lepr Rev; 1993 Jun; 64(2):104-9. PubMed ID: 8341112
[TBL] [Abstract][Full Text] [Related]
17. Use of the ML-Flow test as a tool in classifying and treating leprosy.
Contin LA; Alves CJ; Fogagnolo L; Nassif PW; Barreto JA; Lauris JR; Nogueira ME
An Bras Dermatol; 2011; 86(1):91-5. PubMed ID: 21437528
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing leprosy: revisiting the role of the slit-skin smear with critical analysis of the applicability of polymerase chain reaction in diagnosis.
Banerjee S; Biswas N; Kanti Das N; Sil A; Ghosh P; Hasanoor Raja AH; Dasgupta S; Kanti Datta P; Bhattacharya B
Int J Dermatol; 2011 Dec; 50(12):1522-7. PubMed ID: 22097999
[TBL] [Abstract][Full Text] [Related]
19. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy.
Martinez AN; Britto CF; Nery JA; Sampaio EP; Jardim MR; Sarno EN; Moraes MO
J Clin Microbiol; 2006 Sep; 44(9):3154-9. PubMed ID: 16954241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
